Organogenesis Holdings Inc. Class A Common Stock

ORGONASDAQ • USD
0.90 USD
↘ 0.04 (3.78%)🟢LIVE (AS OF 01:28 PM EDT)
🟢Market: OPEN

ORGO is currently priced at $0.90. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ORGO is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 26, 2026.

Open?$0.94
High?$0.95
Low?$0.89
Prev. Close?$0.94
Volume?457.9K
Avg. Volume?765.6K
VWAP?$0.92
Rel. Volume?0.60x
Bid / Ask
Bid?$0.78 × 100
Ask?$0.90 × 100
Spread?$0.12
Midpoint?$0.84
Valuation & Ratios
Market Cap?121.0M
Shares Out?128.7M
Float?71.9M
Float %?55.9%
P/E Ratio?N/A
P/B Ratio?0.82
EPS?-$0.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Employees
854
Market Cap
120.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-11-29
Address
85 DAN ROAD
CANTON, MA 02021
Phone: 781-575-0775
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
17
Momentum?
69
Short Sent.?
19
Piotroski F-Score?1/9Weak
Altman Z-Score?1.35Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.67%Squeeze Risk
Short Interest?15.6M
Days to Cover?21.2
Free Float71.9M
Avg Daily Volume736.9K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.52Strong
Quick Ratio?3.00Strong
Cash Ratio?0.81Adequate
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.82CHEAP▾
P/S?
Peers
100
S&P
97
0.26CHEAP▾
P/FCF?
Peers
100
S&P
97
5.8CHEAP▾
EV/EBITDA?
S&P
97
-9.3CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.19CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-69.4%WEAK▾
ROA?
S&P
3
-25.3%WEAK▾
Cash Flow & Enterprise
FCF?$20.8M
Enterprise Value?$86.5M
Fundamentals ratios updated end of day